Temefos

Temefos

SCHEMBL10748097

CNc1ccncc1.COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 3/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ DDAH1 O94760 1/20 0.35
▸ NOS1 P29475 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ PTGIR P43119 6/20 0.33
▸ TDP1 Q9NUW8 1/20 0.32
▸ ROCK2 O75116 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Temefos SCHEMBL44105 0.82 LMNA (0.53) ALDH1A1LMNACYP3A4HSD17B10SMN1; SMN2
Temefos SCHEMBL23303378 0.82 LMNA (0.53) ALDH1A1LMNACYP3A4HSD17B10SMN1; SMN2
Temefos SCHEMBL8741692 0.80 LMNA (0.51) ALDH1A1LMNACYP3A4HSD17B10SMN1; SMN2
Temefos SCHEMBL6388031 0.80 LMNA (0.51) ALDH1A1LMNACYP3A4HSD17B10SMN1; SMN2
Temefos SCHEMBL10455340 0.76 LMNA (0.47) ALDH1A1LMNACYP3A4HSD17B10SMN1; SMN2
Temefos SCHEMBL15553439 0.76 LMNA (0.51) ALDH1A1LMNACYP3A4HSD17B10SMN1; SMN2
Temefos SCHEMBL9435846 0.73 LMNA (0.40) ALDH1A1LMNACYP3A4HSD17B10SMN1; SMN2
SCHEMBL30412917 0.71 CYP3A4 (0.53) ALDH1A1LMNACYP3A4HSD17B10SMN1; SMN2
Temefos SCHEMBL9193178 0.71 LMNA (0.54) ALDH1A1LMNACYP3A4HSD17B10SMN1; SMN2
SCHEMBL11061618 0.70 ALDH1A1 (0.57) ALDH1A1LMNACYP3A4HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0230068-A2 Use of a geminal diphosphonic acid compound to prepare a medicament Norwich Eaton Pharmaceuticals, Inc. (US) 1987-07-29 — — EP disclosed
Send feedback